Skip to main content
Premium Trial:

Request an Annual Quote

Genizon Receives $8.5M in Financing from Pfizer, BTF

NEW YORK (GenomeWeb News) - Genizon today said it has raised CA$10 million ($8.5 million) in series D equity financing from Pfizer and Dutch venture capital company BTF.
Pfizer’s investment is related to a licensing agreement it signed with Genizon in mid-January. At the time, Genizon said that Pfizer had taken an equity stake in the firm, but it did not disclose the amount of the investment.  
CFO Henry Bretecher told GenomeWeb News that the breakdown in investment was "roughly half and half" between Pfizer and BTF.
BTF has been an investor in Genizon, formerly called Galileo Genomics, since 2001, when it participated in a $16.5 million financing round. BTF also participated in the company’s $5.2 million round in 2003.
The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.